Long-Term Assets: The sum of all assets classified as non-current.
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) had Long-Term Assets of $1.25M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-24.22M |
|
-- |
|
-- |
|
$25.46M |
|
$-25.46M |
|
$1.24M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-25.46M |
|
$-25.39M |
|
11.75M |
|
11.75M |
|
$-2.06 |
|
$-2.06 |
|
| Balance Sheet Financials | |
$20.90M |
|
$0.30M |
|
|
Long-Term Assets |
$1.25M |
$22.15M |
|
$4.84M |
|
-- |
|
$0.32M |
|
$5.15M |
|
$17.00M |
|
$17.00M |
|
$17.00M |
|
14.21M |
|
| Cash Flow Statement Financials | |
$-23.61M |
|
$15.88M |
|
$3.50M |
|
$13.60M |
|
$9.37M |
|
$-4.23M |
|
$1.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-142.50% |
|
-142.50% |
|
-109.34% |
|
-142.50% |
|
$1.20 |
|
$-2.01 |
|
$-2.01 |
|